34 results on '"Corroyer-Dulmont, Aurélien"'
Search Results
2. Assessment of hypoxia and oxidative-related changes in a lung-derived brain metastasis model by [64Cu][Cu(ATSM)] PET and proteomic studies
- Author
-
Fantin, Jade, Toutain, Jérôme, Pérès, Elodie A., Bernay, Benoit, Mehani, Sarina Maya, Helaine, Charly, Bourgeois, Mickael, Brunaud, Carole, Chazalviel, Laurent, Pontin, Julien, Corroyer-Dulmont, Aurélien, Valable, Samuel, Cherel, Michel, and Bernaudin, Myriam
- Published
- 2023
- Full Text
- View/download PDF
3. Artificial intelligence-based PET denoising could allow a two-fold reduction in [18F]FDG PET acquisition time in digital PET/CT
- Author
-
Weyts, Kathleen, Lasnon, Charline, Ciappuccini, Renaud, Lequesne, Justine, Corroyer-Dulmont, Aurélien, Quak, Elske, Clarisse, Bénédicte, Roussel, Laurent, Bardet, Stéphane, and Jaudet, Cyril
- Published
- 2022
- Full Text
- View/download PDF
4. Nanosized zeolites as a gas delivery platform in a glioblastoma model
- Author
-
Anfray, Clément, Komaty, Sarah, Corroyer-Dulmont, Aurélien, Zaarour, Moussa, Helaine, Charly, Ozcelik, Hayriye, Allioux, Clélia, Toutain, Jérôme, Goldyn, Kamila, Petit, Edwige, Bordji, Karim, Bernaudin, Myriam, Valtchev, Valentin, Touzani, Omar, Mintova, Svetlana, and Valable, Samuel
- Published
- 2020
- Full Text
- View/download PDF
5. Multimodal evaluation of hypoxia in brain metastases of lung cancer and interest of hypoxia image-guided radiotherapy
- Author
-
Corroyer-Dulmont, Aurélien, Valable, Samuel, Fantin, Jade, Chatre, Laurent, Toutain, Jérôme, Teulier, Sylvain, Bazille, Céline, Letissier, Elise, Levallet, Jérôme, Divoux, Didier, Ibazizène, Méziane, Guillouet, Stéphane, Perrio, Cécile, Barré, Louisa, Serres, Sébastien, Sibson, Nicola R., Chapon, Françoise, Levallet, Guénaëlle, and Bernaudin, Myriam
- Published
- 2021
- Full Text
- View/download PDF
6. Improved outcome of 131I-mIBG treatment through combination with external beam radiotherapy in the SK-N-SH mouse model of neuroblastoma
- Author
-
Corroyer-Dulmont, Aurélien, Falzone, Nadia, Kersemans, Veerle, Thompson, James, Allen, Danny P., Able, Sarah, Kartsonaki, Christiana, Malcolm, Javian, Kinchesh, Paul, Hill, Mark A., Vojnovic, Boris, Smart, Sean C., Gaze, Mark N., and Vallis, Katherine A.
- Published
- 2017
- Full Text
- View/download PDF
7. Assessment of hypoxia and oxidative-related changes in a lung-derived brain metastasis model by [64Cu][Cu(ATSM)] PET and proteomic studies.
- Author
-
Fantin, Jade, Toutain, Jérôme, Pérès, Elodie A., Bernay, Benoit, Mehani, Sarina Maya, Helaine, Charly, Bourgeois, Mickael, Brunaud, Carole, Chazalviel, Laurent, Pontin, Julien, Corroyer-Dulmont, Aurélien, Valable, Samuel, Cherel, Michel, and Bernaudin, Myriam
- Subjects
COPPER ,BRAIN metastasis ,PROTEOMICS ,HYPOXEMIA ,MAGNETIC resonance imaging ,LUNGS - Abstract
Background: Brain metastases (BM) are the most frequent malignant brain tumors. The aim of this study was to characterize the tumor microenvironment (TME) of BM and particularly hypoxia and redox state, known to play a role in tumor growth and treatment resistance with multimodal PET and MRI imaging, immunohistochemical and proteomic approaches in a human lung cancer (H2030-BrM3)-derived BM model in rats. Results: First, in vitro studies confirmed that H2030-BrM3 cells respond to hypoxia with increasing expression of HIF-1, HIF-2 and their target genes. Proteomic analyses revealed, among expression changes, proteins associated with metabolism, oxidative stress, metal response and hypoxia signaling in particular in cortical BM. [
64 Cu][Cu(ATSM)] PET revealed a significant uptake by cortical BM (p < 0.01), while no uptake is observed in striatal BM 23 days after tumor implantation. Pimonidazole, HIF-1α, HIF-2α, CA-IX as well as GFAP, CTR1 and DMT1 immunostainings are positive in both BM. Conclusion: Overall, [64 Cu][Cu(ATSM)] imaging and proteomic results showed the presence of hypoxia and protein expression changes linked to hypoxia and oxidative stress in BM, which are more pronounced in cortical BM compared to striatal BM. Moreover, it emphasized the interest of [64 Cu][Cu(ATSM)] PET to characterize TME of BM and depict inter-metastasis heterogeneity that could be useful to guide treatments. [ABSTRACT FROM AUTHOR]- Published
- 2023
- Full Text
- View/download PDF
8. Application of a new spectral deconvolution method for in vitro dosimetry in assessment of targeted alpha therapy.
- Author
-
Doudard, Alexis, Corroyer‐Dulmont, Aurélien, Jaudet, Cyril, Bernaudin, Myriam, Valable, Samuel, Ledoux, Xavier, and Frelin‐Labalme, Anne‐Marie
- Subjects
- *
DECONVOLUTION (Mathematics) , *SILICON detectors , *MONTE Carlo method , *CONCENTRATION gradient , *NUCLIDES , *ISOTOPES - Abstract
Background: The improvement of in vitro assessment of targeted alpha therapy (reproducibility, comparability of experiments...) requires precise evaluation of the dose delivered to the cells. To answer this need, a previous study proposed an innovative dosimetry method based on α‐spectroscopy and a specific deconvolution process to recover the spatial distribution of 212Pb isotopes inside in vitro culture wells. Nevertheless, although promising, the deconvolution method was time consuming and only tested for a simple isotope decay chain. Purpose: The purpose of this work is to propose a new matrix deconvolution method of α spectra based on a constrained‐non‐negative‐maximum‐likelihood decomposition, both faster and offering a greater modelling flexibility, allowing to study independently the kinetics of each of the daughter nuclides of complex decay chains (illustrated here with 223Ra) in in vitro culture wells. Methods: Firstly, the performance of the new method was fully evaluated through Monte Carlo simulations of in vitro irradiations. Different spatial distributions of 212Pb and 223Ra, the corresponding α spectra measured by a silicon detector and the doses delivered to the cells were simulated with Geant4. The deconvolution results were then compared to the simulation results. Secondly, measurements were carried out in culture wells without cells containing 15 kBq of 212Pb or 9.3 kBq of 223Ra, placed above silicon detectors recording α spectra in real time. The matrix deconvolution was then applied to determine the spatial and temporal distribution of all α‐emitting daughters of studied isotopes. Results: The matrix deconvolution was proved to recover the simulated distribution gradients, ensuring simulated doses within 3 % for both tested radionuclides, with errors on dose normally distributed around the reference value (consequently not exhibiting any bias), even in the case of complex decay chains as 223Ra. The experimental study of 212Pb and 223Ra showed highly inhomogeneous distributions and time evolution of the concentration gradients, consistent with the previous study. Furthermore, it highlighted the complex kinetics of 223Ra with different distributions of its α‐emitting daughters (219Rn, 215Po, 215At, 211Bi, 211Po). Conclusions: This study validates a new deconvolution method, fast and flexible, that proved to be accurate and reliable. This method allowed to reveal the complexity of isotopes kinetics in in vitro experiments, especially with complex decay chains. Experimental dosimetry, necessary to improve reliability of in vitro studies in targeted alpha therapy, is demonstrated to be feasible with the proposed method. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
9. Deep Learning Denoising Improves and Homogenizes Patient [ 18 F]FDG PET Image Quality in Digital PET/CT.
- Author
-
Weyts, Kathleen, Quak, Elske, Licaj, Idlir, Ciappuccini, Renaud, Lasnon, Charline, Corroyer-Dulmont, Aurélien, Foucras, Gauthier, Bardet, Stéphane, and Jaudet, Cyril
- Subjects
POSITRON emission tomography ,DEEP learning ,CONVOLUTIONAL neural networks ,SIGNAL convolution ,RADIATION protection - Abstract
Given the constant pressure to increase patient throughput while respecting radiation protection, global body PET image quality (IQ) is not satisfactory in all patients. We first studied the association between IQ and other variables, in particular body habitus, on a digital PET/CT. Second, to improve and homogenize IQ, we evaluated a deep learning PET denoising solution (Subtle PET
TM ) using convolutional neural networks. We analysed retrospectively in 113 patients visual IQ (by a 5-point Likert score in two readers) and semi-quantitative IQ (by the coefficient of variation in the liver, CVliv ) as well as lesion detection and quantification in native and denoised PET. In native PET, visual and semi-quantitative IQ were lower in patients with larger body habitus (p < 0.0001 for both) and in men vs. women (p ≤ 0.03 for CVliv ). After PET denoising, visual IQ scores increased and became more homogeneous between patients (4.8 ± 0.3 in denoised vs. 3.6 ± 0.6 in native PET; p < 0.0001). CVliv were lower in denoised PET than in native PET, 6.9 ± 0.9% vs. 12.2 ± 1.6%; p < 0.0001. The slope calculated by linear regression of CVliv according to weight was significantly lower in denoised than in native PET (p = 0.0002), demonstrating more uniform CVliv . Lesion concordance rate between both PET series was 369/371 (99.5%), with two lesions exclusively detected in native PET. SUVmax and SUVpeak of up to the five most intense native PET lesions per patient were lower in denoised PET (p < 0.001), with an average relative bias of −7.7% and −2.8%, respectively. DL-based PET denoising by Subtle PETTM allowed [18 F]FDG PET global image quality to be improved and homogenized, while maintaining satisfactory lesion detection and quantification. DL-based denoising may render body habitus adaptive PET protocols unnecessary, and pave the way for the improvement and homogenization of PET modalities. [ABSTRACT FROM AUTHOR]- Published
- 2023
- Full Text
- View/download PDF
10. Multimodal imaging based on MRI and PET reveals [18F]FLT PET as a specific and early indicator of treatment efficacy in a preclinical model of recurrent glioblastoma
- Author
-
Corroyer-Dulmont, Aurélien, Pérès, Elodie A., Gérault, Aurélie N., Savina, Ariel, Bouquet, Fanny, Divoux, Didier, Toutain, Jérôme, Ibazizène, Méziane, MacKenzie, Eric T., Barré, Louisa, Bernaudin, Myriam, Petit, Edwige, and Valable, Samuel
- Published
- 2016
- Full Text
- View/download PDF
11. Imaging of brain oxygenation with magnetic resonance imaging: A validation with positron emission tomography in the healthy and tumoural brain
- Author
-
Valable, Samuel, Corroyer-Dulmont, Aurélien, Chakhoyan, Ararat, Durand, Lucile, Toutain, Jérôme, Divoux, Didier, Barré, Louisa, MacKenzie, Eric T, Petit, Edwige, Bernaudin, Myriam, Touzani, Omar, and Barbier, Emmanuel L
- Published
- 2017
- Full Text
- View/download PDF
12. Carbogen-induced increases in tumor oxygenation depend on the vascular status of the tumor: A multiparametric MRI study in two rat glioblastoma models
- Author
-
Chakhoyan, Ararat, Corroyer-Dulmont, Aurélien, Leblond, Marine M, Gérault, Aurélie, Toutain, Jérôme, Chazaviel, Laurent, Divoux, Didier, Petit, Edwige, MacKenzie, Eric T, Kauffmann, François, Delcroix, Nicolas, Bernaudin, Myriam, Touzani, Omar, and Valable, Samuel
- Published
- 2017
- Full Text
- View/download PDF
13. Magnetic resonance imaging of hypoxia in acute stroke compared with fluorine‐18 fluoromisonidazole‐positron emission tomography: A cross‐validation study?
- Author
-
Valable, Samuel, Toutain, Jérôme, Divoux, Didier, Chazalviel, Laurent, Corroyer‐Dulmont, Aurélien, Chakhoyan, Ararat, Guillouet, Stéphane, Bernaudin, Myriam, Barbier, Emmanuel L., and Touzani, Omar
- Subjects
MAGNETIC resonance imaging ,ISCHEMIC stroke ,POSITRON emission tomography ,HYPOXEMIA ,OXYGEN saturation - Abstract
Acute ischemic stroke results in an ischemic core surrounded by a tissue at risk, named the penumbra, which is potentially salvageable. One way to differentiate the tissues is to measure the hypoxia status. The purpose of the current study is to correlate the abnormal brain tissue volume derived from magnetic resonance‐based imaging of brain oxygen saturation (StO2‐MRI) to the fluorine‐18 fluoromisonidazole ([18F]FMISO) positron emission tomography (PET) volume for hypoxia imaging validation, and to analyze the ability of StO2‐MRI to depict the different hypoxic tissue types in the acute phase of stroke. In a pertinent model of stroke in the rat, the volume of tissue with decreased StO2‐MRI signal and that with increased uptake of [18F]FMISO were equivalent and correlated (r = 0.706; p = 0.015). The values of StO2 in the tissue at risk were significantly greater than those quantified in the core of the lesion, and were less than those for healthy tissue (52.3% ± 2.0%; 43.3% ± 1.9%, and 67.9 ± 1.4%, respectively). A threshold value for StO2 of ≈60% as the cut‐off for the identification of the tissue at risk was calculated. Tissue volumes with reduced StO2‐MRI correlated with the final lesion (r = 0.964, p < 0.0001). The findings show that the StO2‐MRI approach is sensitive for the detection of hypoxia and for the prediction of the final lesion after stroke. Once validated in acute clinical settings, this approach might be used to enhance the stratification of patients for potential therapeutic interventions. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
14. Deep Hybrid Learning Prediction of Patient-Specific Quality Assurance in Radiotherapy: Implementation in Clinical Routine.
- Author
-
Moreau, Noémie, Bonnor, Laurine, Jaudet, Cyril, Lechippey, Laetitia, Falzone, Nadia, Batalla, Alain, Bertaut, Cindy, and Corroyer-Dulmont, Aurélien
- Subjects
BLENDED learning ,DEEP learning ,MACHINE learning ,QUALITY assurance ,RADIOTHERAPY - Abstract
Background: Arc therapy allows for better dose deposition conformation, but the radiotherapy plans (RT plans) are more complex, requiring patient-specific pre-treatment quality assurance (QA). In turn, pre-treatment QA adds to the workload. The objective of this study was to develop a predictive model of Delta4-QA results based on RT-plan complexity indices to reduce QA workload. Methods. Six complexity indices were extracted from 1632 RT VMAT plans. A machine learning (ML) model was developed for classification purpose (two classes: compliance with the QA plan or not). For more complex locations (breast, pelvis and head and neck), innovative deep hybrid learning (DHL) was trained to achieve better performance. Results. For not complex RT plans (with brain and thorax tumor locations), the ML model achieved 100% specificity and 98.9% sensitivity. However, for more complex RT plans, specificity falls to 87%. For these complex RT plans, an innovative QA classification method using DHL was developed and achieved a sensitivity of 100% and a specificity of 97.72%. Conclusions. The ML and DHL models predicted QA results with a high degree of accuracy. Our predictive QA online platform is offering substantial time savings in terms of accelerator occupancy and working time. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
15. Artificial intelligence-based PET denoising could allow a two-fold reduction in [18F]FDG PET acquisition time in digital PET/CT.
- Author
-
Weyts, Kathleen, Lasnon, Charline, Ciappuccini, Renaud, Lequesne, Justine, Corroyer-Dulmont, Aurélien, Quak, Elske, Clarisse, Bénédicte, Roussel, Laurent, Bardet, Stéphane, and Jaudet, Cyril
- Subjects
ARTIFICIAL neural networks ,LEAN body mass ,CONVOLUTIONAL neural networks ,INTRACLASS correlation ,DEEP learning ,POSITRON emission tomography - Abstract
Purpose: We investigated whether artificial intelligence (AI)-based denoising halves PET acquisition time in digital PET/CT. Methods: One hundred ninety-five patients referred for [
18 F]FDG PET/CT were prospectively included. Body PET acquisitions were performed in list mode. Original "PET90" (90 s/bed position) was compared to reconstructed ½-duration PET (45 s/bed position) with and without AI-denoising, "PET45AI and PET45". Denoising was performed by SubtlePET™ using deep convolutional neural networks. Visual global image quality (IQ) 3-point scores and lesion detectability were evaluated. Lesion maximal and peak standardized uptake values using lean body mass (SULmax and SULpeak ), metabolic volumes (MV), and liver SULmean were measured, including both standard and EARL1 (European Association of Nuclear Medicine Research Ltd) compliant SUL. Lesion-to-liver SUL ratios (LLR) and liver coefficients of variation (CVliv ) were calculated. Results: PET45 showed mediocre IQ (scored poor in 8% and moderate in 68%) and lesion concordance rate with PET90 (88.7%). In PET45AI, IQ scores were similar to PET90 (P = 0.80), good in 92% and moderate in 8% for both. The lesion concordance rate between PET90 and PET45AI was 836/856 (97.7%), with 7 lesions (0.8%) only detected in PET90 and 13 (1.5%) exclusively in PET45AI. Lesion EARL1 SULpeak was not significantly different between both PET (P = 0.09). Lesion standard SULpeak , standard and EARL1 SULmax , LLR and CVliv were lower in PET45AI than in PET90 (P < 0.0001), while lesion MV and liver SULmean were higher (P < 0.0001). Good to excellent intraclass correlation coefficients (ICC) between PET90 and PET45AI were observed for lesion SUL and MV (ICC ≥ 0.97) and for liver SULmean (ICC ≥ 0.87). Conclusion: AI allows [18 F]FDG PET duration in digital PET/CT to be halved, while restoring degraded ½-duration PET image quality. Future multicentric studies, including other PET radiopharmaceuticals, are warranted. [ABSTRACT FROM AUTHOR]- Published
- 2022
- Full Text
- View/download PDF
16. Noninvasive assessment of hypoxia with 3-[18 F]-fluoro-1-(2-nitro-1-imidazolyl)-2-propanol ([18 F]-FMISO): a PET study in two experimental models of human glioma
- Author
-
Corroyer-Dulmont, Aurélien, Pérès, Elodie A., Petit, Edwige, Durand, Lucile, Marteau, Léna, Toutain, Jérôme, Divoux, Didier, Roussel, Simon, MacKenzie, Eric T., Barré, Louisa, Bernaudin, Myriam, and Valable, Samuel
- Published
- 2013
- Full Text
- View/download PDF
17. Radioimmunotherapy for Brain Metastases: The Potential for Inflammation as a Target of Choice.
- Author
-
Corroyer-Dulmont, Aurélien, Jaudet, Cyril, Frelin, Anne-Marie, Fantin, Jade, Weyts, Kathleen, Vallis, Katherine A., Falzone, Nadia, Sibson, Nicola R., Chérel, Michel, Kraeber-Bodéré, Françoise, Batalla, Alain, Bardet, Stéphane, Bernaudin, Myriam, and Valable, Samuel
- Subjects
BRAIN metastasis ,RADIOIMMUNOTHERAPY ,OVERALL survival ,EXTERNAL beam radiotherapy ,INFLAMMATION - Abstract
Brain metastases (BM) are frequently detected during the follow-up of patients with malignant tumors, particularly in those with advanced disease. Despite a major progress in systemic anti-cancer treatments, the average overall survival of these patients remains limited (6 months from diagnosis). Also, cognitive decline is regularly reported especially in patients treated with whole brain external beam radiotherapy (WBRT), due to the absorbed radiation dose in healthy brain tissue. New targeted therapies, for an earlier and/or more specific treatment of the tumor and its microenvironment, are needed. Radioimmunotherapy (RIT), a combination of a radionuclide to a specific antibody, appears to be a promising tool. Inflammation, which is involved in multiple steps, including the early phase, of BM development is attractive as a relevant target for RIT. This review will focus on the (1) early biomarkers of inflammation in BM pertinent for RIT, (2) state of the art studies on RIT for BM, and (3) the importance of dosimetry to RIT in BM. These two last points will be addressed in comparison to the conventional EBRT treatment, particularly with respect to the balance between tumor control and healthy tissue complications. Finally, because new diagnostic imaging techniques show a potential for the detection of BM at an early stage of the disease, we focus particularly on this therapeutic window. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
18. The Impact of Artificial Intelligence CNN Based Denoising on FDG PET Radiomics.
- Author
-
Jaudet, Cyril, Weyts, Kathleen, Lechervy, Alexis, Batalla, Alain, Bardet, Stéphane, and Corroyer-Dulmont, Aurélien
- Subjects
RADIOMICS ,FEATURE extraction ,ARTIFICIAL intelligence ,POSITRON emission tomography ,PHYSICIANS - Abstract
Background: With a constantly increasing number of diagnostic images performed each year, Artificial Intelligence (AI) denoising methods offer an opportunity to respond to the growing demand. However, it may affect information in the image in an unknown manner. This study quantifies the effect of AI-based denoising on FDG PET textural information in comparison to a convolution with a standard gaussian postfilter (EARL1). Methods: The study was carried out on 113 patients who underwent a digital FDG PET/CT (VEREOS, Philips Healthcare). 101 FDG avid lesions were segmented semi-automatically by a nuclear medicine physician. VOIs in the liver and lung as reference organs were contoured. PET textural features were extracted with pyradiomics. Texture features from AI denoised and EARL1 versus original PET images were compared with a Concordance Correlation Coefficient (CCC). Features with CCC values ≥ 0.85 threshold were considered concordant. Scatter plots of variable pairs with R2 coefficients of the more relevant features were computed. A Wilcoxon signed rank test to compare the absolute values between AI denoised and original images was performed. Results: The ratio of concordant features was 90/104 (86.5%) in AI denoised versus 46/104 (44.2%) with EARL1 denoising. In the reference organs, the concordant ratio for AI and EARL1 denoised images was low, respectively 12/104 (11.5%) and 7/104 (6.7%) in the liver, 26/104 (25%) and 24/104 (23.1%) in the lung. SUVpeak was stable after the application of both algorithms in comparison to SUVmax. Scatter plots of variable pairs showed that AI filtering affected more lower versus high intensity regions unlike EARL1 gaussian post filters, affecting both in a similar way. In lesions, the majority of texture features 79/100 (79%) were significantly (p<0.05) different between AI denoised and original PET images. Conclusions: Applying an AI-based denoising on FDG PET images maintains most of the lesion's texture information in contrast to EARL1-compatible Gaussian filter. Predictive features of a trained model could be thus the same, however with an adapted threshold. Artificial intelligence based denoising in PET is a very promising approach as it adapts the denoising in function of the tissue type, preserving information where it should. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
19. Radionuclide spatial distribution and dose deposition for in vitro assessments of 212Pb‐αVCAM‐1 targeted alpha therapy.
- Author
-
Frelin‐Labalme, Anne‐Marie, Roger, Thomas, Falzone, Nadia, Quan Lee, Boon, Sibson, Nicola R., Vallis, Katherine A., Bernaudin, Myriam, Valable, Samuel, and Corroyer‐Dulmont, Aurélien
- Subjects
MONTE Carlo method ,SPATIAL distribution (Quantum optics) ,RADIOISOTOPES ,SILICON detectors ,ALPHA rhythm ,ABSORBED dose ,CELL culture ,ENERGY transfer - Abstract
Purpose: Targeted alpha therapy (TAT) takes advantage of the short‐range and high‐linear energy transfer of α‐particles and is increasingly used, especially for the treatment of metastatic lesions. Nevertheless, dosimetry of α‐emitters is challenging for the very same reasons, even for in vitro experiments. Assumptions, such as the uniformity of the distribution of radionuclides in the culture medium, are commonly made, which could have a profound impact on dose calculations. In this study we measured the spatial distribution of α‐emitting 212Pb coupled to an anti‐VCAM‐1 antibody (212Pb‐αVCAM‐1) and its evolution over time in the context of in vitro irradiations. Methods: Two experimental setups were implemented without cells to measure α‐particle count rates and energy spectra in culture medium containing 15 kBq of 212Pb‐α‐VCAM‐1. Silicon detectors were placed above and below cell culture dishes for 20 h. One of the dishes had a 2.5‐µm‐thick mylar‐base allowing easy detection of the α‐particles. Monte Carlo simulations were performed to analyze experimental spectra. Experimental setups were modeled and α‐energy spectra were simulated in the silicon detectors for different decay positions in the culture medium. Simulated spectra were then used to deconvolute experimental spectra to determine the spatial distribution of 212Pb‐αVCAM‐1 in the medium. This distribution was finally used to calculate the dose deposition in cell culture experiments. Results: Experimental count rates and energy spectra showed differences in measurements taken at the top and the bottom of dishes and temporal variations that did not follow 212Pb decay. The radionuclide spatial distribution was shown to be composed of a uniform distribution and concentration gradients at the top and the bottom, which were subjected to temporal variations that may be explained by gravity and electrostatic attraction. The absorbed dose in cells calculated from this distribution was compared with the dose expected for a uniform and static distribution and found to be 1.75 times higher, which is highly significant to interpret biological observations. Conclusions: This study demonstrated that accurate dosimetry of α‐emitters requires the experimental determination of radionuclide spatial and temporal distribution and highlighted that in vitro assessment of dose for TAT cannot only rely on a uniform distribution of activity in the culture medium. The reliability and reproducibility of future experiments should benefit from specifically developed dosimetry tools and methods. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
20. VCAM-1 targeted alpha-particle therapy for early brain metastases.
- Author
-
Corroyer-Dulmont, Aurélien, Valable, Samuel, Falzone, Nadia, Frelin-Labalme, Anne-Marie, Tietz, Ole, Toutain, Jérôme, Soto, Manuel Sarmiento, Divoux, Didier, Chazalviel, Laurent, Pérès, Elodie A, Sibson, Nicola R, Vallis, Katherine A, and Bernaudin, Myriam
- Published
- 2020
- Full Text
- View/download PDF
21. MRI-guided radiotherapy of the SK-N-SH neuroblastoma xenograft model using a small animal radiation research platform.
- Author
-
CORROYER-DULMONT, AURÉLIEN, FALZONE, NADIA, KERSEMANS, VEERLE, THOMPSON, JAMES, HILL, MARK, ALLEN, P. DANNY, BEECH, JOHN, GILCHRIST, STUART, KINCHESH, PAUL, VOJNOVIC, BORIS, TULLIS, IAIN, GAZE, MARK N., SMART, SEAN, and VALLIS, KATHERINE A.
- Abstract
Objective: Neuroblastoma has one of the lowest survival rates of all childhood cancers, despite the use of intensive treatment regimens. Preclinical models of neuroblastoma are essential for testing new multimodality protocols, including those that involve radiotherapy (RT). The aim of this study was to develop a robust method for RT planning and tumour response monitoring based on combined MRI and cone-beam CT (CBCT) imaging and to apply it to a widely studied mouse xenograft model of neuroblastoma, SK-N-SH. Methods: As part of a tumour growth inhibition study, SK-N-SH xenografts were generated in BALB/c nu/nu mice. Mice (n = 8) were placed in a printed MR- and CT-compatible plastic cradle, imaged using a 4.7-T MRI scanner and then transferred to a small animal radiation research platform (SARRP) irradiator with on-board CBCT. MRI/CBCT co-registration was performed to enable RT planning using the soft-tissue contrast afforded by MRI prior to delivery of RT (5 Gy). Tumour response was assessed by serial MRI and calliper measurements. Results: SK-N-SH xenografts formed soft, deformable tumours that could not be differentiated from surrounding normal tissues using CBCT. MR images, which allowed clear delineation of tumours, were successfully co-registered with CBCT images, allowing conformal RT to be delivered. MRI measurements of tumour volume 4 days after RT correlated strongly with length of survival time. Conclusion: MRI allowed precision RT of SK-N-SH tumours and provided an accurate means of measuring tumour response. Advances in knowledge: MRI-based RT planning of murine tumours is feasible using an SARRP irradiator. [ABSTRACT FROM AUTHOR]
- Published
- 2017
- Full Text
- View/download PDF
22. Multimodal imaging based on MRI and PET reveals [F]FLT PET as a specific and early indicator of treatment efficacy in a preclinical model of recurrent glioblastoma.
- Author
-
Corroyer-Dulmont, Aurélien, Pérès, Elodie, Gérault, Aurélie, Savina, Ariel, Bouquet, Fanny, Divoux, Didier, Toutain, Jérôme, Ibazizène, Méziane, MacKenzie, Eric, Barré, Louisa, Bernaudin, Myriam, Petit, Edwige, and Valable, Samuel
- Subjects
MAGNETIC resonance imaging ,POSITRON emission tomography ,GLIOBLASTOMA multiforme treatment ,TUMOR growth ,TEMOZOLOMIDE ,BEVACIZUMAB - Abstract
Purpose: The primary objective of this study was to compare the ability of PET and MRI biomarkers to predict treatment efficacy in a preclinical model of recurrent glioblastoma multiforme. Methods: MRI (anatomical, diffusion, vasculature and oxygenation) and PET ([F]FDG and [F]FLT) parameters were obtained 3 days after the end of treatment and compared with late tumour growth and survival. Results: Early after tumour recurrence, no effect of treatment with temozolomide combined with bevacizumab was observed on tumour volume as assessed by T2-W MRI. At later times, the treatment decreased tumour volume and increased survival. Interestingly, at the earlier time, temozolomide + bevacizumab decreased [F]FLT uptake, cerebral blood volume and oedema. [F]FLT uptake, oedema and cerebral blood volume were correlated with overall survival but [F]FLT uptake had the highest specificity and sensitivity for the early prediction of treatment efficacy. Conclusion: The present investigation in a preclinical model of glioblastoma recurrence underscores the importance of multimodal imaging in the assessment of oedema, tumour vascular status and cell proliferation. Finally, [F]FLT holds the greatest promise for the early assessment of treatment efficacy. These findings may translate clinically in that individualized treatment for recurrent glioma could be prescribed for patients selected after PET/MRI examinations. [ABSTRACT FROM AUTHOR]
- Published
- 2016
- Full Text
- View/download PDF
23. The Impact of Resampling and Denoising Deep Learning Algorithms on Radiomics in Brain Metastases MRI.
- Author
-
Moummad, Ilyass, Jaudet, Cyril, Lechervy, Alexis, Valable, Samuel, Raboutet, Charlotte, Soilihi, Zamila, Thariat, Juliette, Falzone, Nadia, Lacroix, Joëlle, Batalla, Alain, and Corroyer-Dulmont, Aurélien
- Subjects
BRAIN ,DEEP learning ,METASTASIS ,MAGNETIC resonance imaging ,RETROSPECTIVE studies ,BRAIN tumors ,T-test (Statistics) ,DESCRIPTIVE statistics ,DATA analysis software ,STATISTICAL models ,ALGORITHMS - Abstract
Simple Summary: Due to the central role of magnetic resonance Imaging (MRI) in the management of patients with cancer, waiting lists exceed clinically relevant delays. For this reason, many research groups and MRI manufacturers develop algorithms as resampling and denoising models to allow faster acquisition time without deterioration in image quality. Whereas these algorithms are available in all new MRI, it is not clear how they will impact image features as well as the validity of statistical model of radiomics which use deep images characteristics to predict treatment outcome. The aim of this study was to develop resampling and denoising deep learning (DL) models and evaluate their impact on radiomics from post-Gd-T1w-MRI brain images with brain metastases. We show that resampling and denoising DL models reconstruct low resolution and noised MRI images acquired quickly into high quality images. While fast acquisition loses most of the radiomic-features and invalidates predictive radiomic models, DL models restore these parameters. Background: Magnetic resonance imaging (MRI) is predominant in the therapeutic management of cancer patients, unfortunately, patients have to wait a long time to get an appointment for examination. Therefore, new MRI devices include deep-learning (DL) solutions to save acquisition time. However, the impact of these algorithms on intensity and texture parameters has been poorly studied. The aim of this study was to evaluate the impact of resampling and denoising DL models on radiomics. Methods: Resampling and denoising DL model was developed on 14,243 T1 brain images from 1.5T-MRI. Radiomics were extracted from 40 brain metastases from 11 patients (2049 images). A total of 104 texture features of DL images were compared to original images with paired t-test, Pearson correlation and concordance-correlation-coefficient (CCC). Results: When two times shorter image acquisition shows strong disparities with the originals concerning the radiomics, with significant differences and loss of correlation of 79.81% and 48.08%, respectively. Interestingly, DL models restore textures with 46.15% of unstable parameters and 25.96% of low CCC and without difference for the first-order intensity parameters. Conclusions: Resampling and denoising DL models reconstruct low resolution and noised MRI images acquired quickly into high quality images. While fast MRI acquisition loses most of the radiomic features, DL models restore these parameters. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
24. Noninvasive assessment of hypoxia with 3-[18F]-fluoro-1-(2-nitro-1-imidazolyl)-2-propanol ([18F]-FMISO): a PET study in two experimental models of human glioma.
- Author
-
Corroyer-Dulmont, Aurélien, Pérès, Elodie A., Petit, Edwige, Durand, Lucile, Marteau, Léna, Toutain, Jérôme, Divoux, Didier, Roussel, Simon, MacKenzie, Eric T., Barré, Louisa, Bernaudin, Myriam, and Valable, Samuel
- Subjects
- *
GLIOMA treatment , *HYPOXIA-inducible factors , *PROPANOLS , *NONINVASIVE diagnostic tests , *POSITRON emission tomography , *MAGNETIC resonance imaging of cancer , *IMMUNOHISTOCHEMISTRY - Abstract
Despite multiple advances in cancer therapies, patients with glioblastoma (GBM) still have a poor prognosis. Numerous glioma models are used not only for the development of innovative therapies but also to optimize conventional ones. Given the significance of hypoxia in drug and radiation resistance and that hypoxia is widely observed among GBM, the establishment of a reliable method to map hypoxia in preclinical human models may contribute to the discovery and translation of future and more targeted therapies. The aim of this study was to compare the hypoxic status of two commonly used human orthotopic glioma models (U87 and U251) developed in rats and studied by noninvasive hypoxia imaging with 3-[18F]fluoro-1-(2-nitro-1-imidazolyl)-2-propanol-micro-positron emission tomography ([18F]-FMISO-μPET). In parallel, because of the relationships between angiogenesis and hypoxia, we used magnetic resonance imaging (MRI), histology, and immunohistochemistry to characterize the tumoral vasculature. Although all tumors were detectable in T2-weighted MRI and 2-deoxy-2-[18F]fluoro- d-glucose-μPET, only the U251 model exhibited [18F]-FMISO uptake. Additionally, the U251 tumors were less densely vascularized than U87 tumors. Our study demonstrates the benefits of noninvasive imaging of hypoxia in preclinical models to define the most reliable one for translation of future therapies to clinic based on the importance of intratumoral oxygen tension for the efficacy of chemotherapy and radiotherapy. [ABSTRACT FROM AUTHOR]
- Published
- 2013
- Full Text
- View/download PDF
25. Detection of glioblastoma response to temozolomide combined with bevacizumab based on µMRI and µPET imaging reveals [18F]-fluoro-l-thymidine as an early and robust predictive marker for treatment efficacy.
- Author
-
Corroyer-Dulmont, Aurélien, Pérès, Elodie A., Petit, Edwige, Guillamo, Jean-Sébastien, Varoqueaux, Nathalie, Roussel, Simon, Toutain, Jérôme, Divoux, Didier, MacKenzie, Eric T., Delamare, Jérôme, Ibazizène, Méziane, Lecocq, Myriam, Jacobs, Andréas H., Barré, Louisa, Bernaudin, Myriam, and Valable, Samuel
- Published
- 2013
- Full Text
- View/download PDF
26. Hypoxia induces macrophage polarization and re-education toward an M2 phenotype in U87 and U251 glioblastoma models.
- Author
-
Leblond, Marine M, Gérault, Aurélie N, Corroyer-Dulmont, Aurélien, MacKenzie, Eric T, Petit, Edwige, Bernaudin, Myriam, and Valable, Samuel
- Subjects
HYPOXIA (Water) ,MACROPHAGES ,PHENOTYPES ,BRAIN tumors ,GLIOBLASTOMA multiforme ,PROGNOSIS - Abstract
Hypoxia is a common feature of solid tumors, particularly in glioblastoma (GBM), and known to be a poor prognosis factor in GBM patients. The growth of GBM is also associated with a marked inflammation partially characterized by an accumulation of macrophage (MΦ) of the M2 phenotype. However, the transition between M1 MΦ (antitumoral) and M2 MΦ (protumoral) phenotypes is a dynamic process. We made the assumption that oxygen (O2) availability could be a major regulator of this transition and that the intratumoral O2gradient is of importance. We evaluated,in vivo, the impact of hypoxia on MΦ tropism and polarization in two models of human GBM, well differentiated by their degree of hypoxia. MΦ migration in the tumor was more pronounced in the more hypoxic tumor of the two GBM models. In the more hypoxic of the models, we have shown that MΦ migrated at the tumor site only when hypoxia takes place. We also demonstrated that the acquisition of the M2 phenotype was clearly an evolving phenomenon with hypoxia as the major trigger for this transition. In support of thesein vivofinding, M0 but also M1 MΦ cultured in moderate or severe hypoxia displayed a phenotype close to that of M2 MΦ whose phenotype was further reinforced by severe hypoxia. These results highlight the role of hypoxia in the aggressiveness of GBM, in part, by transforming MΦ such that a protumoral activity is expressed. [ABSTRACT FROM PUBLISHER]
- Published
- 2016
- Full Text
- View/download PDF
27. Inactivation of the HIF-1α/PDK3 Signaling Axis Drives Melanoma toward Mitochondrial Oxidative Metabolism and Potentiates the Therapeutic Activity of Pro-Oxidants.
- Author
-
Kluza, Jérome, Corazao-Rozas, Paola, Touil, Yasmine, Jendoubi, Manel, Maire, Cyril, Guerreschi, Pierre, Jonneaux, Aurélie, Ballot, Caroline, Balayssac, Stéphane, Valable, Samuel, Corroyer-Dulmont, Aurélien, Bernaudin, Myriam, Malet-Martino, Myriam, de Lassalle, Elisabeth Martin, Maboudou, Patrice, Formstecher, Pierre, Polakowska, Renata, Mortier, Laurent, and Marchetti, Philippe
- Subjects
- *
CANCER cells , *PHOSPHORYLATION , *MELANOMA , *CELL lines , *MITOCHONDRIA , *CANCER treatment - Abstract
Cancer cells can undergo a metabolic reprogramming from oxidative phosphorylation to glycolysis that allows them to adapt to nutrient-poor microenvironments, thereby imposing a selection for aggressive variants. However, the mechanisms underlying this reprogramming are not fully understood. Using complementary approaches in validated cell lines and freshly obtained human specimens, we report here that mitochondrial respiration and oxidative phosphorylation are slowed in metastatic melanomas, even under normoxic conditions due to the persistence of a high nuclear expression of hypoxia-inducible factor-1a (HIF-1α). Pharmacologic or genetic blockades of the HIF-1α pathway decreased glycolysis and promoted mitochondrial respiration via specific reduction in the expression of pyruvate dehydrogenase kinase-3 (PDK3). Inhibiting PDK3 activity by dichloroacetate (DCA) or siRNA-mediated attenuation was sufficient to increase pyruvate dehydrogenase activity, oxidative phosphorylation, and mitochondrial reactive oxygen species generation. Notably, DCA potentiated the antitumor effects of elesclomol, a pro-oxidative drug currently in clinical development, both by limiting cell proliferation and promoting cell death. Interestingly, this combination was also effective against BRAF V600E-mutant melanoma cells that were resistant to the BRAF inhibitor vemurafenib. Cotreatment of melanomas with DCA and elesclomol in vivo achieved a more durable response than single agent alone. Our findings offer a preclinical validation of the HIF-1/PDK3 bioenergetic pathway as a new target for therapeutic intervention in metastatic melanoma, opening the door to innovative combinations that might eradicate this disease. [ABSTRACT FROM AUTHOR]
- Published
- 2012
- Full Text
- View/download PDF
28. The Impact of Resampling and Denoising Deep Learning Algorithms on Radiomics in Brain Metastases MRI.
- Author
-
Moummad I, Jaudet C, Lechervy A, Valable S, Raboutet C, Soilihi Z, Thariat J, Falzone N, Lacroix J, Batalla A, and Corroyer-Dulmont A
- Abstract
Background: Magnetic resonance imaging (MRI) is predominant in the therapeutic management of cancer patients, unfortunately, patients have to wait a long time to get an appointment for examination. Therefore, new MRI devices include deep-learning (DL) solutions to save acquisition time. However, the impact of these algorithms on intensity and texture parameters has been poorly studied. The aim of this study was to evaluate the impact of resampling and denoising DL models on radiomics., Methods: Resampling and denoising DL model was developed on 14,243 T1 brain images from 1.5T-MRI. Radiomics were extracted from 40 brain metastases from 11 patients (2049 images). A total of 104 texture features of DL images were compared to original images with paired t -test, Pearson correlation and concordance-correlation-coefficient (CCC)., Results: When two times shorter image acquisition shows strong disparities with the originals concerning the radiomics, with significant differences and loss of correlation of 79.81% and 48.08%, respectively. Interestingly, DL models restore textures with 46.15% of unstable parameters and 25.96% of low CCC and without difference for the first-order intensity parameters., Conclusions: Resampling and denoising DL models reconstruct low resolution and noised MRI images acquired quickly into high quality images. While fast MRI acquisition loses most of the radiomic features, DL models restore these parameters.
- Published
- 2021
- Full Text
- View/download PDF
29. Radionuclide spatial distribution and dose deposition for in vitro assessments of 212 Pb-αVCAM-1 targeted alpha therapy.
- Author
-
Frelin-Labalme AM, Roger T, Falzone N, Quan Lee B, Sibson NR, Vallis KA, Bernaudin M, Valable S, and Corroyer-Dulmont A
- Subjects
- Immunoconjugates immunology, Monte Carlo Method, Radiotherapy Dosage, Alpha Particles therapeutic use, Immunoconjugates therapeutic use, Lead Radioisotopes therapeutic use, Radiation Dosage, Vascular Cell Adhesion Molecule-1 immunology
- Abstract
Purpose: Targeted alpha therapy (TAT) takes advantage of the short-range and high-linear energy transfer of α-particles and is increasingly used, especially for the treatment of metastatic lesions. Nevertheless, dosimetry of α-emitters is challenging for the very same reasons, even for in vitro experiments. Assumptions, such as the uniformity of the distribution of radionuclides in the culture medium, are commonly made, which could have a profound impact on dose calculations. In this study we measured the spatial distribution of α-emitting
212 Pb coupled to an anti-VCAM-1 antibody (212 Pb-αVCAM-1) and its evolution over time in the context of in vitro irradiations., Methods: Two experimental setups were implemented without cells to measure α-particle count rates and energy spectra in culture medium containing 15 kBq of212 Pb-α-VCAM-1. Silicon detectors were placed above and below cell culture dishes for 20 h. One of the dishes had a 2.5-µm-thick mylar-base allowing easy detection of the α-particles. Monte Carlo simulations were performed to analyze experimental spectra. Experimental setups were modeled and α-energy spectra were simulated in the silicon detectors for different decay positions in the culture medium. Simulated spectra were then used to deconvolute experimental spectra to determine the spatial distribution of212 Pb-αVCAM-1 in the medium. This distribution was finally used to calculate the dose deposition in cell culture experiments., Results: Experimental count rates and energy spectra showed differences in measurements taken at the top and the bottom of dishes and temporal variations that did not follow212 Pb decay. The radionuclide spatial distribution was shown to be composed of a uniform distribution and concentration gradients at the top and the bottom, which were subjected to temporal variations that may be explained by gravity and electrostatic attraction. The absorbed dose in cells calculated from this distribution was compared with the dose expected for a uniform and static distribution and found to be 1.75 times higher, which is highly significant to interpret biological observations., Conclusions: This study demonstrated that accurate dosimetry of α-emitters requires the experimental determination of radionuclide spatial and temporal distribution and highlighted that in vitro assessment of dose for TAT cannot only rely on a uniform distribution of activity in the culture medium. The reliability and reproducibility of future experiments should benefit from specifically developed dosimetry tools and methods., (© 2019 American Association of Physicists in Medicine.)- Published
- 2020
- Full Text
- View/download PDF
30. Hypoxia Imaging and Adaptive Radiotherapy: A State-of-the-Art Approach in the Management of Glioma.
- Author
-
Gérard M, Corroyer-Dulmont A, Lesueur P, Collet S, Chérel M, Bourgeois M, Stefan D, Limkin EJ, Perrio C, Guillamo JS, Dubray B, Bernaudin M, Thariat J, and Valable S
- Abstract
Severe hypoxia [oxygen partial pressure (pO
2 ) below 5-10 mmHg] is more frequent in glioblastoma multiforme (GBM) compared to lower-grade gliomas. Seminal studies in the 1950s demonstrated that hypoxia was associated with increased resistance to low-linear energy transfer (LET) ionizing radiation. In experimental conditions, the total radiation dose has to be multiplied by a factor of 3 to achieve the same cell lethality in anoxic situations. The presence of hypoxia in human tumors is assumed to contribute to treatment failures after radiotherapy (RT) in cancer patients. Therefore, a logical way to overcome hypoxia-induced radioresistance would be to deliver substantially higher doses of RT in hypoxic volumes delineated on pre-treatment imaging as biological target volumes (BTVs). Such an approach faces various fundamental, technical, and clinical challenges. The present review addresses several technical points related to the delineation of hypoxic zones, which include: spatial accuracy, quantitative vs. relative threshold, variations of hypoxia levels during RT, and availability of hypoxia tracers. The feasibility of hypoxia imaging as an assessment tool for early tumor response to RT and for predicting long-term outcomes is discussed. Hypoxia imaging for RT dose painting is likewise examined. As for the radiation oncologist's point of view, hypoxia maps should be converted into dose-distribution objectives for RT planning. Taking into account the physics and the radiobiology of various irradiation beams, preliminary in silico studies are required to investigate the feasibility of dose escalation in terms of normal tissue tolerance before clinical trials are undertaken.- Published
- 2019
- Full Text
- View/download PDF
31. Dosimetric evaluation of radionuclides for VCAM-1-targeted radionuclide therapy of early brain metastases.
- Author
-
Falzone N, Ackerman NL, Rosales LF, Bernal MA, Liu X, Peeters SG, Soto MS, Corroyer-Dulmont A, Bernaudin M, Grimoin E, Touzani O, Sibson NR, and Vallis KA
- Subjects
- DNA Breaks, Double-Stranded radiation effects, Humans, Monte Carlo Method, Tumor Protein, Translationally-Controlled 1, Brain Neoplasms pathology, Brain Neoplasms radiotherapy, Neoplasm Metastasis pathology, Neoplasm Metastasis radiotherapy, Radioisotopes therapeutic use, Vascular Cell Adhesion Molecule-1 metabolism
- Abstract
Brain metastases develop frequently in patients with breast cancer, and present a pressing therapeutic challenge. Expression of vascular cell adhesion molecule 1 (VCAM-1) is upregulated on brain endothelial cells during the early stages of metastasis and provides a target for the detection and treatment of early brain metastases. The aim of this study was to use a model of early brain metastasis to evaluate the efficacy of α-emitting radionuclides,
149 Tb,211 At,212 Pb,213 Bi and225 Ac; β-emitting radionuclides,90 Y,161 Tb and177 Lu; and Auger electron (AE)-emitters67 Ga,89 Zr,111 In and124 I, for targeted radionuclide therapy (TRT)., Methods: Histologic sections and two photon microscopy of mouse brain parenchyma were used to inform a cylindrical vessel geometry using the Geant4 general purpose Monte Carlo (MC) toolkit with the Geant4-DNA low energy physics models. Energy deposition was evaluated as a radial function and the resulting phase spaces were superimposed on a DNA model to estimate double-strand break (DSB) yields for representative β- and α-emitters,177 Lu and212 Pb. Relative biological effectiveness (RBE) values were determined by only evaluating DNA damage due to physical interactions., Results:177 Lu produced 2.69 ± 0.08 DSB per GbpGy, without significant variation from the lumen of the vessel to a radius of 100 µm. The DSB yield of212 Pb included two local maxima produced by the 6.1 MeV and 8.8 MeV α-emissions from decay products,212 Bi and212 Po, with yields of 7.64 ± 0.12 and 9.15 ± 0.24 per GbpGy, respectively. Given its higher DSB yield212 Pb may be more effective for short range targeting of early micrometastatic lesions than177 Lu., Conclusion: MC simulation of a model of early brain metastases provides invaluable insight into the potential efficacy of α-, β- and AE-emitting radionuclides for TRT.212 Pb, which has the attributes of a theranostic radionuclide since it can be used for SPECT imaging, showed a favorable dose profile and RBE., Competing Interests: Competing Interests: The authors have declared that no competing interest exists.- Published
- 2018
- Full Text
- View/download PDF
32. Imaging Modalities to Assess Oxygen Status in Glioblastoma.
- Author
-
Corroyer-Dulmont A, Chakhoyan A, Collet S, Durand L, MacKenzie ET, Petit E, Bernaudin M, Touzani O, and Valable S
- Abstract
Hypoxia, the result of an inadequacy between a disorganized and functionally impaired vasculature and the metabolic demand of tumor cells, is a feature of glioblastoma. Hypoxia promotes the aggressiveness of these tumors and, equally, negatively correlates with a decrease in outcome. Tools to characterize oxygen status are essential for the therapeutic management of patients with glioblastoma (i) to refine prognosis, (ii) to adapt the treatment regimen, and (iii) to assess the therapeutic efficacy. While methods that are focal and invasive in nature are of limited use, non-invasive imaging technologies have been developed. Each of these technologies is characterized by its singular advantages and limitations in terms of oxygenation status in glioblastoma. The aim of this short review is, first, to focus on the interest to characterize hypoxia for a better therapeutic management of patients and, second, to discuss recent and pertinent approaches for the assessment of oxygenation/hypoxia and their direct implication for patient care.
- Published
- 2015
- Full Text
- View/download PDF
33. Hypoxia induces macrophage polarization and re-education toward an M2 phenotype in U87 and U251 glioblastoma models.
- Author
-
Leblond MM, Gérault AN, Corroyer-Dulmont A, MacKenzie ET, Petit E, Bernaudin M, and Valable S
- Abstract
Hypoxia is a common feature of solid tumors, particularly in glioblastoma (GBM), and known to be a poor prognosis factor in GBM patients. The growth of GBM is also associated with a marked inflammation partially characterized by an accumulation of macrophage (MΦ) of the M2 phenotype. However, the transition between M1 MΦ (antitumoral) and M2 MΦ (protumoral) phenotypes is a dynamic process. We made the assumption that oxygen (O
2 ) availability could be a major regulator of this transition and that the intratumoral O2 gradient is of importance. We evaluated, in vivo , the impact of hypoxia on MΦ tropism and polarization in two models of human GBM, well differentiated by their degree of hypoxia. MΦ migration in the tumor was more pronounced in the more hypoxic tumor of the two GBM models. In the more hypoxic of the models, we have shown that MΦ migrated at the tumor site only when hypoxia takes place. We also demonstrated that the acquisition of the M2 phenotype was clearly an evolving phenomenon with hypoxia as the major trigger for this transition. In support of these in vivo finding, M0 but also M1 MΦ cultured in moderate or severe hypoxia displayed a phenotype close to that of M2 MΦ whose phenotype was further reinforced by severe hypoxia. These results highlight the role of hypoxia in the aggressiveness of GBM, in part, by transforming MΦ such that a protumoral activity is expressed.- Published
- 2015
- Full Text
- View/download PDF
34. Noninvasive assessment of hypoxia with 3-[18F]-fluoro-1-(2-nitro-1-imidazolyl)-2-propanol ([18F]-FMISO): a PET study in two experimental models of human glioma.
- Author
-
Corroyer-Dulmont A, Pérès EA, Petit E, Durand L, Marteau L, Toutain J, Divoux D, Roussel S, MacKenzie ET, Barré L, Bernaudin M, and Valable S
- Subjects
- Humans, Immunohistochemistry, Magnetic Resonance Imaging, Magnetic Resonance Spectroscopy, Glioma pathology, Hypoxia diagnosis, Misonidazole analogs & derivatives, Positron-Emission Tomography methods
- Abstract
Despite multiple advances in cancer therapies, patients with glioblastoma (GBM) still have a poor prognosis. Numerous glioma models are used not only for the development of innovative therapies but also to optimize conventional ones. Given the significance of hypoxia in drug and radiation resistance and that hypoxia is widely observed among GBM, the establishment of a reliable method to map hypoxia in preclinical human models may contribute to the discovery and translation of future and more targeted therapies. The aim of this study was to compare the hypoxic status of two commonly used human orthotopic glioma models (U87 and U251) developed in rats and studied by noninvasive hypoxia imaging with 3-[18F]fluoro-1-(2-nitro-1-imidazolyl)-2-propanol-micro-positron emission tomography ([18F]-FMISO-μPET). In parallel, because of the relationships between angiogenesis and hypoxia, we used magnetic resonance imaging (MRI), histology, and immunohistochemistry to characterize the tumoral vasculature. Although all tumors were detectable in T2-weighted MRI and 2-deoxy-2-[18F]fluoro-d-glucose-μPET, only the U251 model exhibited [18F]-FMISO uptake. Additionally, the U251 tumors were less densely vascularized than U87 tumors. Our study demonstrates the benefits of noninvasive imaging of hypoxia in preclinical models to define the most reliable one for translation of future therapies to clinic based on the importance of intratumoral oxygen tension for the efficacy of chemotherapy and radiotherapy.
- Published
- 2013
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.